Studying progression from glucose intolerance to type 2 diabetes in obese children

Abstract Aim Identification of metabolic and genetic factors capable to mediate progression from normal glucose tolerance (NGT) through impaired glucose tolerance (IGT) to type 2 diabetes (T2D) in childhood obesity. Patients and methods Three groups of obese children with NGT ( n = 54), IGT ( n = 35...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes & metabolic syndrome clinical research & reviews 2014-07, Vol.8 (3), p.133-137
Hauptverfasser: Dubinina, Irina A, Chistiakov, Dimitry A, Eremina, Irina A, Brovkin, Alexei N, Zilberman, Lyubov I, Nikitin, Alexei G, Kuraeva, Tamara L, Nosikov, Valery V, Peterkova, Valentina A, Dedov, Ivan I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 137
container_issue 3
container_start_page 133
container_title Diabetes & metabolic syndrome clinical research & reviews
container_volume 8
creator Dubinina, Irina A
Chistiakov, Dimitry A
Eremina, Irina A
Brovkin, Alexei N
Zilberman, Lyubov I
Nikitin, Alexei G
Kuraeva, Tamara L
Nosikov, Valery V
Peterkova, Valentina A
Dedov, Ivan I
description Abstract Aim Identification of metabolic and genetic factors capable to mediate progression from normal glucose tolerance (NGT) through impaired glucose tolerance (IGT) to type 2 diabetes (T2D) in childhood obesity. Patients and methods Three groups of obese children with NGT ( n = 54), IGT ( n = 35), and T2D ( n = 62) were evaluated. A control group of non-obese normal children ( n = 210) was also studied. In obese patients, an oral glucose tolerance test (OGTT) was performed. Insulin resistance (IR) was assessed using HOMA-IR index. Insulin sensitivity (IS) was assessed according to the Matsuda formula. Genomic DNA from obese and control children was genotyped for genetic variants of PPARG, ADIPOQ, ADIPOR1, FTO, TCF7L2, and KCNJ11 using a real-time PCR strategy. The unpaired Student's t -test and Kruskal–Wallis one-way test were used to compare quantitative data in two and more groups. To assess the extent to which the various genetic variants were associated with pathology, ORs (odds ratios) and 95% CI (confidence interval) were estimated. Results In T2D children, HOMA-IR value (7.5 ± 3.1) was significantly ( P < 0.001) higher than that in IGT (4.21 ± 2.25) and NGT (4.1 ± 2.4) subjects. The Matsuda IS index was significantly increased in normoglycemic patients compared to IGT individuals (2.8 ± 1.75 vs. 2.33 ± 1.2, P < 0.05). The Pro12Ala polymorphism of PPARG was significantly associated with obesity (OR = 1.74, 95% CI = 1.19–2.55, P = 0.004) and T2D in obesity (OR = 2.01, 95% CI = 1.24–3.26, P = 0.004). Conclusion IR is a major risk factor that mediates progression from NGT to clinical T2D in Russian obese children. This progression may be genetically influenced by the Pro12Ala variant of PPARG.
doi_str_mv 10.1016/j.dsx.2014.07.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1562427589</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1871402114000642</els_id><sourcerecordid>1562427589</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-acd264d1778e733eaa0630293c411dbc5bd25b2663b26e8be984dd11287ddaf73</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EakvpD-CCfOSSMB47cSIkJFTRglQJiZaz5dizi5dsvNhJxf77etnCoQcuMyP5vafxN4y9FlALEO27Te3z7xpBqBp0DYDP2JnodFeBlOr5n1lUClCcspc5bwCapsf-hJ1iI1BL7M_Yt9t58fswrfkuxXWinEOc-CrFLV-Pi4uZeJjmOFKykyM-Rz7vd8SR-2AHmimXZx4HKjr3I4w-0fSKvVjZMdPFYz9n368-3V1-rm6-Xn-5_HhTOaW7ubLOY6u80LojLSVZC60E7KVTQvjBNYPHZsC2laVQN1DfKe-FwE57b1danrO3x9yy-a-F8my2ITsaRztRXLIRTYsKddP1RSqOUpdizolWZpfC1qa9EWAOKM3GFJTmgNKANgVl8bx5jF-GLfl_jr_siuD9UUDlk_eBkskuUKHkQyI3Gx_Df-M_PHG7MUzB2fEn7Slv4pKmQs8Ik9GAuT3c8nDKUgBahfIBHXGZWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1562427589</pqid></control><display><type>article</type><title>Studying progression from glucose intolerance to type 2 diabetes in obese children</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dubinina, Irina A ; Chistiakov, Dimitry A ; Eremina, Irina A ; Brovkin, Alexei N ; Zilberman, Lyubov I ; Nikitin, Alexei G ; Kuraeva, Tamara L ; Nosikov, Valery V ; Peterkova, Valentina A ; Dedov, Ivan I</creator><creatorcontrib>Dubinina, Irina A ; Chistiakov, Dimitry A ; Eremina, Irina A ; Brovkin, Alexei N ; Zilberman, Lyubov I ; Nikitin, Alexei G ; Kuraeva, Tamara L ; Nosikov, Valery V ; Peterkova, Valentina A ; Dedov, Ivan I</creatorcontrib><description>Abstract Aim Identification of metabolic and genetic factors capable to mediate progression from normal glucose tolerance (NGT) through impaired glucose tolerance (IGT) to type 2 diabetes (T2D) in childhood obesity. Patients and methods Three groups of obese children with NGT ( n = 54), IGT ( n = 35), and T2D ( n = 62) were evaluated. A control group of non-obese normal children ( n = 210) was also studied. In obese patients, an oral glucose tolerance test (OGTT) was performed. Insulin resistance (IR) was assessed using HOMA-IR index. Insulin sensitivity (IS) was assessed according to the Matsuda formula. Genomic DNA from obese and control children was genotyped for genetic variants of PPARG, ADIPOQ, ADIPOR1, FTO, TCF7L2, and KCNJ11 using a real-time PCR strategy. The unpaired Student's t -test and Kruskal–Wallis one-way test were used to compare quantitative data in two and more groups. To assess the extent to which the various genetic variants were associated with pathology, ORs (odds ratios) and 95% CI (confidence interval) were estimated. Results In T2D children, HOMA-IR value (7.5 ± 3.1) was significantly ( P &lt; 0.001) higher than that in IGT (4.21 ± 2.25) and NGT (4.1 ± 2.4) subjects. The Matsuda IS index was significantly increased in normoglycemic patients compared to IGT individuals (2.8 ± 1.75 vs. 2.33 ± 1.2, P &lt; 0.05). The Pro12Ala polymorphism of PPARG was significantly associated with obesity (OR = 1.74, 95% CI = 1.19–2.55, P = 0.004) and T2D in obesity (OR = 2.01, 95% CI = 1.24–3.26, P = 0.004). Conclusion IR is a major risk factor that mediates progression from NGT to clinical T2D in Russian obese children. This progression may be genetically influenced by the Pro12Ala variant of PPARG.</description><identifier>ISSN: 1871-4021</identifier><identifier>EISSN: 1878-0334</identifier><identifier>DOI: 10.1016/j.dsx.2014.07.002</identifier><identifier>PMID: 25127329</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adolescent ; Blood Glucose - metabolism ; Body Mass Index ; Child ; Disease Progression ; Endocrinology &amp; Metabolism ; Genetic Predisposition to Disease ; Glucose tolerance ; Glucose Tolerance Test ; Glycated Hemoglobin A - metabolism ; Humans ; Insulin Resistance ; Insulin sensitivity ; Obesity ; Pediatric Obesity - epidemiology ; Pediatric Obesity - genetics ; Pediatric Obesity - metabolism ; Pediatric Obesity - physiopathology ; Polymorphism, Single Nucleotide - genetics ; PPAR gamma - metabolism ; PPARG ; Risk Factors ; Russia - epidemiology</subject><ispartof>Diabetes &amp; metabolic syndrome clinical research &amp; reviews, 2014-07, Vol.8 (3), p.133-137</ispartof><rights>Diabetes India</rights><rights>2014 Diabetes India</rights><rights>Copyright © 2014 Diabetes India. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-acd264d1778e733eaa0630293c411dbc5bd25b2663b26e8be984dd11287ddaf73</citedby><cites>FETCH-LOGICAL-c478t-acd264d1778e733eaa0630293c411dbc5bd25b2663b26e8be984dd11287ddaf73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.dsx.2014.07.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25127329$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dubinina, Irina A</creatorcontrib><creatorcontrib>Chistiakov, Dimitry A</creatorcontrib><creatorcontrib>Eremina, Irina A</creatorcontrib><creatorcontrib>Brovkin, Alexei N</creatorcontrib><creatorcontrib>Zilberman, Lyubov I</creatorcontrib><creatorcontrib>Nikitin, Alexei G</creatorcontrib><creatorcontrib>Kuraeva, Tamara L</creatorcontrib><creatorcontrib>Nosikov, Valery V</creatorcontrib><creatorcontrib>Peterkova, Valentina A</creatorcontrib><creatorcontrib>Dedov, Ivan I</creatorcontrib><title>Studying progression from glucose intolerance to type 2 diabetes in obese children</title><title>Diabetes &amp; metabolic syndrome clinical research &amp; reviews</title><addtitle>Diabetes Metab Syndr</addtitle><description>Abstract Aim Identification of metabolic and genetic factors capable to mediate progression from normal glucose tolerance (NGT) through impaired glucose tolerance (IGT) to type 2 diabetes (T2D) in childhood obesity. Patients and methods Three groups of obese children with NGT ( n = 54), IGT ( n = 35), and T2D ( n = 62) were evaluated. A control group of non-obese normal children ( n = 210) was also studied. In obese patients, an oral glucose tolerance test (OGTT) was performed. Insulin resistance (IR) was assessed using HOMA-IR index. Insulin sensitivity (IS) was assessed according to the Matsuda formula. Genomic DNA from obese and control children was genotyped for genetic variants of PPARG, ADIPOQ, ADIPOR1, FTO, TCF7L2, and KCNJ11 using a real-time PCR strategy. The unpaired Student's t -test and Kruskal–Wallis one-way test were used to compare quantitative data in two and more groups. To assess the extent to which the various genetic variants were associated with pathology, ORs (odds ratios) and 95% CI (confidence interval) were estimated. Results In T2D children, HOMA-IR value (7.5 ± 3.1) was significantly ( P &lt; 0.001) higher than that in IGT (4.21 ± 2.25) and NGT (4.1 ± 2.4) subjects. The Matsuda IS index was significantly increased in normoglycemic patients compared to IGT individuals (2.8 ± 1.75 vs. 2.33 ± 1.2, P &lt; 0.05). The Pro12Ala polymorphism of PPARG was significantly associated with obesity (OR = 1.74, 95% CI = 1.19–2.55, P = 0.004) and T2D in obesity (OR = 2.01, 95% CI = 1.24–3.26, P = 0.004). Conclusion IR is a major risk factor that mediates progression from NGT to clinical T2D in Russian obese children. This progression may be genetically influenced by the Pro12Ala variant of PPARG.</description><subject>Adolescent</subject><subject>Blood Glucose - metabolism</subject><subject>Body Mass Index</subject><subject>Child</subject><subject>Disease Progression</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Genetic Predisposition to Disease</subject><subject>Glucose tolerance</subject><subject>Glucose Tolerance Test</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>Humans</subject><subject>Insulin Resistance</subject><subject>Insulin sensitivity</subject><subject>Obesity</subject><subject>Pediatric Obesity - epidemiology</subject><subject>Pediatric Obesity - genetics</subject><subject>Pediatric Obesity - metabolism</subject><subject>Pediatric Obesity - physiopathology</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>PPAR gamma - metabolism</subject><subject>PPARG</subject><subject>Risk Factors</subject><subject>Russia - epidemiology</subject><issn>1871-4021</issn><issn>1878-0334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhS0EakvpD-CCfOSSMB47cSIkJFTRglQJiZaz5dizi5dsvNhJxf77etnCoQcuMyP5vafxN4y9FlALEO27Te3z7xpBqBp0DYDP2JnodFeBlOr5n1lUClCcspc5bwCapsf-hJ1iI1BL7M_Yt9t58fswrfkuxXWinEOc-CrFLV-Pi4uZeJjmOFKykyM-Rz7vd8SR-2AHmimXZx4HKjr3I4w-0fSKvVjZMdPFYz9n368-3V1-rm6-Xn-5_HhTOaW7ubLOY6u80LojLSVZC60E7KVTQvjBNYPHZsC2laVQN1DfKe-FwE57b1danrO3x9yy-a-F8my2ITsaRztRXLIRTYsKddP1RSqOUpdizolWZpfC1qa9EWAOKM3GFJTmgNKANgVl8bx5jF-GLfl_jr_siuD9UUDlk_eBkskuUKHkQyI3Gx_Df-M_PHG7MUzB2fEn7Slv4pKmQs8Ik9GAuT3c8nDKUgBahfIBHXGZWQ</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Dubinina, Irina A</creator><creator>Chistiakov, Dimitry A</creator><creator>Eremina, Irina A</creator><creator>Brovkin, Alexei N</creator><creator>Zilberman, Lyubov I</creator><creator>Nikitin, Alexei G</creator><creator>Kuraeva, Tamara L</creator><creator>Nosikov, Valery V</creator><creator>Peterkova, Valentina A</creator><creator>Dedov, Ivan I</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140701</creationdate><title>Studying progression from glucose intolerance to type 2 diabetes in obese children</title><author>Dubinina, Irina A ; Chistiakov, Dimitry A ; Eremina, Irina A ; Brovkin, Alexei N ; Zilberman, Lyubov I ; Nikitin, Alexei G ; Kuraeva, Tamara L ; Nosikov, Valery V ; Peterkova, Valentina A ; Dedov, Ivan I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-acd264d1778e733eaa0630293c411dbc5bd25b2663b26e8be984dd11287ddaf73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Blood Glucose - metabolism</topic><topic>Body Mass Index</topic><topic>Child</topic><topic>Disease Progression</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Genetic Predisposition to Disease</topic><topic>Glucose tolerance</topic><topic>Glucose Tolerance Test</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>Humans</topic><topic>Insulin Resistance</topic><topic>Insulin sensitivity</topic><topic>Obesity</topic><topic>Pediatric Obesity - epidemiology</topic><topic>Pediatric Obesity - genetics</topic><topic>Pediatric Obesity - metabolism</topic><topic>Pediatric Obesity - physiopathology</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>PPAR gamma - metabolism</topic><topic>PPARG</topic><topic>Risk Factors</topic><topic>Russia - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dubinina, Irina A</creatorcontrib><creatorcontrib>Chistiakov, Dimitry A</creatorcontrib><creatorcontrib>Eremina, Irina A</creatorcontrib><creatorcontrib>Brovkin, Alexei N</creatorcontrib><creatorcontrib>Zilberman, Lyubov I</creatorcontrib><creatorcontrib>Nikitin, Alexei G</creatorcontrib><creatorcontrib>Kuraeva, Tamara L</creatorcontrib><creatorcontrib>Nosikov, Valery V</creatorcontrib><creatorcontrib>Peterkova, Valentina A</creatorcontrib><creatorcontrib>Dedov, Ivan I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes &amp; metabolic syndrome clinical research &amp; reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dubinina, Irina A</au><au>Chistiakov, Dimitry A</au><au>Eremina, Irina A</au><au>Brovkin, Alexei N</au><au>Zilberman, Lyubov I</au><au>Nikitin, Alexei G</au><au>Kuraeva, Tamara L</au><au>Nosikov, Valery V</au><au>Peterkova, Valentina A</au><au>Dedov, Ivan I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Studying progression from glucose intolerance to type 2 diabetes in obese children</atitle><jtitle>Diabetes &amp; metabolic syndrome clinical research &amp; reviews</jtitle><addtitle>Diabetes Metab Syndr</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>8</volume><issue>3</issue><spage>133</spage><epage>137</epage><pages>133-137</pages><issn>1871-4021</issn><eissn>1878-0334</eissn><abstract>Abstract Aim Identification of metabolic and genetic factors capable to mediate progression from normal glucose tolerance (NGT) through impaired glucose tolerance (IGT) to type 2 diabetes (T2D) in childhood obesity. Patients and methods Three groups of obese children with NGT ( n = 54), IGT ( n = 35), and T2D ( n = 62) were evaluated. A control group of non-obese normal children ( n = 210) was also studied. In obese patients, an oral glucose tolerance test (OGTT) was performed. Insulin resistance (IR) was assessed using HOMA-IR index. Insulin sensitivity (IS) was assessed according to the Matsuda formula. Genomic DNA from obese and control children was genotyped for genetic variants of PPARG, ADIPOQ, ADIPOR1, FTO, TCF7L2, and KCNJ11 using a real-time PCR strategy. The unpaired Student's t -test and Kruskal–Wallis one-way test were used to compare quantitative data in two and more groups. To assess the extent to which the various genetic variants were associated with pathology, ORs (odds ratios) and 95% CI (confidence interval) were estimated. Results In T2D children, HOMA-IR value (7.5 ± 3.1) was significantly ( P &lt; 0.001) higher than that in IGT (4.21 ± 2.25) and NGT (4.1 ± 2.4) subjects. The Matsuda IS index was significantly increased in normoglycemic patients compared to IGT individuals (2.8 ± 1.75 vs. 2.33 ± 1.2, P &lt; 0.05). The Pro12Ala polymorphism of PPARG was significantly associated with obesity (OR = 1.74, 95% CI = 1.19–2.55, P = 0.004) and T2D in obesity (OR = 2.01, 95% CI = 1.24–3.26, P = 0.004). Conclusion IR is a major risk factor that mediates progression from NGT to clinical T2D in Russian obese children. This progression may be genetically influenced by the Pro12Ala variant of PPARG.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>25127329</pmid><doi>10.1016/j.dsx.2014.07.002</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1871-4021
ispartof Diabetes & metabolic syndrome clinical research & reviews, 2014-07, Vol.8 (3), p.133-137
issn 1871-4021
1878-0334
language eng
recordid cdi_proquest_miscellaneous_1562427589
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adolescent
Blood Glucose - metabolism
Body Mass Index
Child
Disease Progression
Endocrinology & Metabolism
Genetic Predisposition to Disease
Glucose tolerance
Glucose Tolerance Test
Glycated Hemoglobin A - metabolism
Humans
Insulin Resistance
Insulin sensitivity
Obesity
Pediatric Obesity - epidemiology
Pediatric Obesity - genetics
Pediatric Obesity - metabolism
Pediatric Obesity - physiopathology
Polymorphism, Single Nucleotide - genetics
PPAR gamma - metabolism
PPARG
Risk Factors
Russia - epidemiology
title Studying progression from glucose intolerance to type 2 diabetes in obese children
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T18%3A01%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Studying%20progression%20from%20glucose%20intolerance%20to%20type%202%20diabetes%20in%20obese%20children&rft.jtitle=Diabetes%20&%20metabolic%20syndrome%20clinical%20research%20&%20reviews&rft.au=Dubinina,%20Irina%20A&rft.date=2014-07-01&rft.volume=8&rft.issue=3&rft.spage=133&rft.epage=137&rft.pages=133-137&rft.issn=1871-4021&rft.eissn=1878-0334&rft_id=info:doi/10.1016/j.dsx.2014.07.002&rft_dat=%3Cproquest_cross%3E1562427589%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1562427589&rft_id=info:pmid/25127329&rft_els_id=S1871402114000642&rfr_iscdi=true